Effect of dorzolamide/timolol combination on the visual field in glaucoma

PURPOSE: To evaluate the effect of treatment for 3 years with a dorzolamide/timolol (1%/0.5%) fixed combination (DTFC) on visual field progression in patients with open-angle glaucoma. PARTICIPANTS: A total of 14 consecutive patients were enrolled who had been previously treated with monotherapy or...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Sakurako, Mimura, Tatsuya, Matsubara, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154893/
https://www.ncbi.nlm.nih.gov/pubmed/25210425
http://dx.doi.org/10.2147/OPTH.S71162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154893/
https://www.ncbi.nlm.nih.gov/pubmed/25210425
http://dx.doi.org/10.2147/OPTH.S71162

Ejemplares similares